Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Journal of Nephrology
|
July 25, 2023
Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy
Francesca Menniti-Ippolito, Alfonso Mele, Roberto Da Cas, et al.
Pharmacoepidemiology and Drug Safety
|
October 17, 2020
Direct healthcare costs of chronic kidney disease management in Italy: What cost-savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis-stimulating agents?
Ylenia Ingrasciotta, Janet Sultana, Dario Formica, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
October 10, 2019
In Search of Predictors of Switching Between Erythropoiesis-Stimulating Agents in Clinical Practice: A Multi-Regional Cohort Study
Ylenia Ingrasciotta, Valeria Belleudi, Francesco Trotta, et al.
Frontiers in Endocrinology
|
March 30, 2018
Pattern of Use of Biosimilar and Originator Somatropin in Italy: A Population-Based Multiple Databases Study During the Years 2009-2014
Ilaria Marcianò, Ylenia Ingrasciotta, Francesco Giorgianni, et al.
Vaccines
|
September 27, 2025
Humoral Response to the Third Dose of SARS-CoV-2 Vaccine Among Dialysis Patients: A Breakthrough Infection Case-Control Study
Francesca Colavita, Concetta Castilletti, Giulia Matusali, et al.
Drug Safety
|
July 27, 2024
Acute Appendicitis After COVID-19 Vaccines in Italy: A Self-Controlled Case Series Study
Cristina Morciano, Marco Massari, Maria Cutillo, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
May 4, 2016
How did the Introduction of Biosimilar Filgrastim Influence the Prescribing Pattern of Granulocyte Colony-Stimulating Factors? Results from a Multicentre, Population-Based Study, from Five Italian Centres in the Years 2009-2014
Ilaria Marcianò, Ylenia Ingrasciotta, Francesco Giorgianni, et al.
Drug Safety
|
October 1, 2018
The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand?
Gianluca Trifirò, Rosa Gini, Francesco Barone-Adesi, et al.
Annali Dell'Istituto Superiore Di Sanita
|
December 21, 2020
Turmeric (Curcuma longa L.) food supplements and hepatotoxicity: an integrated evaluation approach
Francesca Menniti-Ippolito, Ilaria Ippoliti, Augusto Alberto Pastorelli, et al.
Vaccine
|
June 26, 2014
Vaccine effectiveness against severe laboratory-confirmed influenza in children: results of two consecutive seasons in Italy
Francesca Menniti-Ippolito, Roberto Da Cas, Giuseppe Traversa, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Journal of Nephrology
|
July 25, 2023
Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy
Francesca Menniti-Ippolito, Alfonso Mele, Roberto Da Cas, et al.
Pharmacoepidemiology and Drug Safety
|
October 17, 2020
Direct healthcare costs of chronic kidney disease management in Italy: What cost-savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis-stimulating agents?
Ylenia Ingrasciotta, Janet Sultana, Dario Formica, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
October 10, 2019
In Search of Predictors of Switching Between Erythropoiesis-Stimulating Agents in Clinical Practice: A Multi-Regional Cohort Study
Ylenia Ingrasciotta, Valeria Belleudi, Francesco Trotta, et al.
Frontiers in Endocrinology
|
March 30, 2018
Pattern of Use of Biosimilar and Originator Somatropin in Italy: A Population-Based Multiple Databases Study During the Years 2009-2014
Ilaria Marcianò, Ylenia Ingrasciotta, Francesco Giorgianni, et al.
Vaccines
|
September 27, 2025
Humoral Response to the Third Dose of SARS-CoV-2 Vaccine Among Dialysis Patients: A Breakthrough Infection Case-Control Study
Francesca Colavita, Concetta Castilletti, Giulia Matusali, et al.
Drug Safety
|
July 27, 2024
Acute Appendicitis After COVID-19 Vaccines in Italy: A Self-Controlled Case Series Study
Cristina Morciano, Marco Massari, Maria Cutillo, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
May 4, 2016
How did the Introduction of Biosimilar Filgrastim Influence the Prescribing Pattern of Granulocyte Colony-Stimulating Factors? Results from a Multicentre, Population-Based Study, from Five Italian Centres in the Years 2009-2014
Ilaria Marcianò, Ylenia Ingrasciotta, Francesco Giorgianni, et al.
Drug Safety
|
October 1, 2018
The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand?
Gianluca Trifirò, Rosa Gini, Francesco Barone-Adesi, et al.
Annali Dell'Istituto Superiore Di Sanita
|
December 21, 2020
Turmeric (Curcuma longa L.) food supplements and hepatotoxicity: an integrated evaluation approach
Francesca Menniti-Ippolito, Ilaria Ippoliti, Augusto Alberto Pastorelli, et al.
Vaccine
|
June 26, 2014
Vaccine effectiveness against severe laboratory-confirmed influenza in children: results of two consecutive seasons in Italy
Francesca Menniti-Ippolito, Roberto Da Cas, Giuseppe Traversa, et al.
Page
of 5